Treating tumors with the monoclonal antibody herceptin can bypass drug resistance problems.
Tumors can develop drug resistance to single angiogenic factor treatments, and with the exception of a cocktail of multiple anti-angiogenic drugs, there are few other treatments available to overcome this problem. But in March 21
Izumi
"As a single agent that acts against multiple targets, herceptin, or drugs like it, may offer a simple alternative to combination anti-angiogenic treatments," concluded the authors.
A citizen science game explores how social choices and networks can influence how an illness moves through a population.
View this Issue
By fine-tuning polishing conditions, scientists attain high titers of infectious lentiviral particles during purification.
Learn how a next-generation platform accelerates biological research by enabling high-throughput, spatially resolved multiomics profiling.
In this webinar, Imogen Binnian will share how AI and gene synthesis technology can accelerate the discovery and validation of novel disease traits.
Real-time imaging enhances fluorescence activated cell sorting (FACS) to help scientists overcome the cost and burden of validation.
Setting new standards for intelligent mass detection, sensitivity, and sustainability.
Compact, Powerful, and now Mass Spec-Connected for Superior Analytical Performance
The Wellcome Sanger Institute, Helmholtz Munich, and Parse Biosciences have announced a landmark international collaboration to create a Cancer Plasticity Atlas.
Multi-center project will profile over 40,000 samples using ultra-sensitive NULISA™ technology.
